Stocks
NovaBridge BiosciencesNBP
NASDAQHealthcareBiotechnology$1.37
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing novel therapies for rare genetic disorders, with a pipeline focused on gene editing and RNA-based modalities. Its lead candidate is in Phase 2 trials for a metabolic disease, and investors track the stock for its potential in a high-value niche market.
52W Range: $1.25-$5.19
Congressional Interest in NovaBridge Biosciences (NBP)
No congressional trades have been disclosed for NovaBridge Biosciences (NBP) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading NBP?
No congressional trades found for this stock.